Show simple item record

dc.contributor.authorFouad, Mona N.
dc.contributor.authorMayo, Charlotte P.
dc.contributor.authorFunkhouser, Ellen M.
dc.contributor.authorHall, H. Irene
dc.contributor.authorUrban, Donald A.
dc.contributor.authorKiefe, Catarina I.
dc.date2022-08-11T08:10:42.000
dc.date.accessioned2022-08-23T17:17:19Z
dc.date.available2022-08-23T17:17:19Z
dc.date.issued2004-09-11
dc.date.submitted2010-04-27
dc.identifier.citationJ Clin Epidemiol. 2004 Jul;57(7):721-9. <a href="http://dx.doi.org/10.1016/j.jclinepi.2003.11.009">Link to article on publisher's site</a>
dc.identifier.issn0895-4356 (Linking)
dc.identifier.doi10.1016/j.jclinepi.2003.11.009
dc.identifier.pmid15358400
dc.identifier.urihttp://hdl.handle.net/20.500.14038/47601
dc.description.abstractOBJECTIVE: The purpose of this study was to examine the proportion of men who died from prostate cancer (PrCa) vs. with PrCa and assess the comorbid conditions associated with other-cause deaths. STUDY DESIGN AND SETTING: We identified all male decedents aged >/=65 years in Jefferson County, AL, in 1993-1995. By crosslinking three databases (death certificate, Medicare, and Veteran's Administration), we identified men whose deaths might have been caused by PrCa. We abstracted and reviewed medical records to rate comorbid conditions and determine whether or not death was due to PrCa. RESULTS: Of 561 men with a premortem diagnosis of PrCa, 42% died from PrCa and 53% died with PrCA; 50.2% of blacks died from PrCa vs. 36.9% of Whites. Other factors related to dying with PrCa included older age at death and a serious, or very serious, comorbid condition. Treatment did not have an independent effect on cause of death (i.e., death with vs. from PrCa). CONCLUSIONS: Comorbidity was an independent predictor of dying with PrCa, even after adjustment for ethnicity, age, and treatment. Given the as yet unproven benefit of PrCa screening, our results extend the body of information relevant to the screening decision; among men dying with a diagnosis of PrCa, only about 1/3 to 1/2 died from the disease.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=15358400&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/j.jclinepi.2003.11.009
dc.subjectAfrican Continental Ancestry Group
dc.subjectAge Distribution
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectAlabama
dc.subjectCardiovascular Diseases
dc.subjectCause of Death
dc.subjectComorbidity
dc.subjectEuropean Continental Ancestry Group
dc.subjectHumans
dc.subjectMale
dc.subjectNeoplasms
dc.subjectProstatic Neoplasms
dc.subjectPulmonary Disease, Chronic Obstructive
dc.subjectRetrospective Studies
dc.subjectSeverity of Illness Index
dc.subjectBioinformatics
dc.subjectBiostatistics
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleComorbidity independently predicted death in older prostate cancer patients, more of whom died with than from their disease
dc.typeJournal Article
dc.source.journaltitleJournal of clinical epidemiology
dc.source.volume57
dc.source.issue7
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qhs_pp/73
dc.identifier.contextkey1287818
html.description.abstract<p>OBJECTIVE: The purpose of this study was to examine the proportion of men who died from prostate cancer (PrCa) vs. with PrCa and assess the comorbid conditions associated with other-cause deaths.</p> <p>STUDY DESIGN AND SETTING: We identified all male decedents aged >/=65 years in Jefferson County, AL, in 1993-1995. By crosslinking three databases (death certificate, Medicare, and Veteran's Administration), we identified men whose deaths might have been caused by PrCa. We abstracted and reviewed medical records to rate comorbid conditions and determine whether or not death was due to PrCa.</p> <p>RESULTS: Of 561 men with a premortem diagnosis of PrCa, 42% died from PrCa and 53% died with PrCA; 50.2% of blacks died from PrCa vs. 36.9% of Whites. Other factors related to dying with PrCa included older age at death and a serious, or very serious, comorbid condition. Treatment did not have an independent effect on cause of death (i.e., death with vs. from PrCa).</p> <p>CONCLUSIONS: Comorbidity was an independent predictor of dying with PrCa, even after adjustment for ethnicity, age, and treatment. Given the as yet unproven benefit of PrCa screening, our results extend the body of information relevant to the screening decision; among men dying with a diagnosis of PrCa, only about 1/3 to 1/2 died from the disease.</p>
dc.identifier.submissionpathqhs_pp/73
dc.contributor.departmentDepartment of Quantitative Health Sciences
dc.source.pages721-9


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record